(NaturalNews) After 40 years of unsuccessful attempts to develop a vaccine to prevent type 1 diabetes, a joint effort by California-based Stanford University
and Leiden University Medical Center
in the Netherlands announced this past Wednesday that they may have stumbled upon the key to finally make it happen. Their article - published in the journal Science Translational Medicine
- releases Phase 2 data that it has genetically engineered a vaccine to shut down specific aspects of the immune system that leads to type 1 diabetes, while doing no harm to the immune system as a whole.
Researchers proved their hypothesis "that an engineered DNA plasmid encoding proinsulin (BHT-3021) would preserve s cell function in [type 1 diabetes] patients through reduction of insulin-specific CD8+ T cells," through intramuscular injection in 80 participants with Type 1 diabetes.
We don't need all of our parts just some, right?
As ridiculous as this sounds, what is the difference between the claims this article makes and a mechanic claiming that a perfectly well-functioning engine will not be adversely affected by shutting down just one part? It would be absurd to assume that an engine can run without an alternator or carburetor. So, why are researchers asking people to believe that the human body - the most intricate engine of all - is not dependent on every component of its immune system? It is an irrevocable fact that any drug or vaccine that inhibits proper any aspect of immune function will naturally cascade to effect the entire body in one way or another.
Blatant conflict of interest
According to the Wall Street Journal
, Lawrence Steinman - professor at the Stanford University School of Medicine
and co-founder of Tolerion, Inc. - commented, "Until now the only treatment for type 1 diabetes
was insulin replacement, a 100-year old therapy that is very disruptive to patients' lives and involves serious long-term health risks. These promising Phase 2 data indicate that TOL-3021 may stop the destruction of pancreatic beta cells and improve the long-term outlook for patients with type 1 diabetes
, even in adults with long-established disease. Based on these results, we are eager to test TOL-3021 in a larger trial with longer dosing beyond 12 weeks, and to assess whether it might slow or stop disease progression entirely in younger patients when administered before large numbers of beta calls have been destroyed."
The WSJ reports that the rights to the vaccine and associated product pipeline are licensed by Tolerion by Stanford University
The truth about type 1 diabetes
Previously known as juvenile diabetes, type 1 diabetes occurs when the body does not produce insulin and is usually diagnosed in children and young adults. According to the Mayo Clinic, "The exact cause of type 1 diabetes is unknown." However, it is suspected that the "body's own immune system
- which normally fights harmful bacteria and viruses - mistakenly destroys the insulin-producing (islet) cells in the pancreas. Genetics may play a role in this process, and exposure to certain viruses may trigger the disease."
How a vaccine
can help the body produce insulin naturally is unclear and is, in fact, absolutely absurd. It is also morally reprehensible that millions of dollars of grant monies have been spent these past 40 years trying to genetically engineer one as its efficacy is far-fetched at best.
Believed to be an "autoimmune" disorder by nature, it would best serve type 1 diabetic patients to do whatever is in their power to boost their immune systems; thereby, avoiding gluten, casein, and processed sugars at all costs. Eating a diet filled with whole, natural foods, drinking filtered water, regularly practicing mind/body practices like Tai Chi, and regularly visiting their chiropractor to ensure their nervous system is maximally functioning could do them wonders.Sources for this article include:http://science.naturalnews.com/pubmed/12956615.htmlhttp://www.reuters.comhttp://stm.sciencemag.org/content/5/191/191ra82http://online.wsj.com/article/PR-CO-20130626-909026.htmlhttp://www.diabetes.org/diabetes-basics/type-1/http://www.mayoclinic.comAbout the author:
Journalist, medical researcher, speaker, and life coach, Eric L. Zielinski has been writing prolifically since 1998. Formerly trained as primary care provider and peer-review researcher, he has published an eclectic selection of health content for several print and online publications. Zielinski earned his Bachelor of Arts in English from Wayne State University in 2002 and is currently wrapping up his Doctorate of Chiropractic at Life University along with a Masters of Public Health at Emory University. Visit his blog. Track his work on facebook. Read Eric's other naturalnews.com articles.